Water quality report for Palm Beach Shores, FL — PFAS, lead and copper results, violation history and state inspection findings from EPA SDWIS.
A look at Palm Beach Shores's drinking water using EPA enforcement records: violations, lead and copper results, PFAS sampling and state inspection findings.
Lead is 2.40 ppb, 16% of the action level and no violations are open. However, PFAS exceeds the federal limit at 1 of 1 sampling points, running as high as 6.75 times the limit.
Graded on violations, lead, and PFAS, with state inspection findings.
| Contaminant | Type | Measured | Limit | Period | Status |
|---|---|---|---|---|---|
| E. COLI | MONITORING AND REPORTING | — | 0 | 2024 | Resolved |
| E. COLI | MONITORING AND REPORTING | — | 0 | 2024 | Resolved |
| Revised Total Coliform Rule | MONITORING FAILURE | — | — | 2024 | Resolved |
| TTHM | MONITORING AND REPORTING | — | 0.080 mg/L | 2024 | Archived |
| Total Haloacetic Acids (HAA5) | MONITORING AND REPORTING | — | 0.060 mg/L | 2024 | Archived |
| Revised Total Coliform Rule | MONITORING FAILURE | — | — | 2024 | Resolved |
| E. COLI | MONITORING AND REPORTING | — | 0 | 2024 | Resolved |
| E. COLI | MONITORING AND REPORTING | — | 0 | 2023 | Addressed |
| E. COLI | MONITORING AND REPORTING | — | 0 | 2023 | Addressed |
| Revised Total Coliform Rule | REPORTING FAILURE | — | — | 2023 | Addressed |
| Revised Total Coliform Rule | MCL EXCEEDANCE | — | — | 2023 | Archived |
| E. COLI | MONITORING AND REPORTING | — | 0 | 2023 | Addressed |
| E. COLI | MONITORING AND REPORTING | — | 0 | 2023 | Addressed |
| Public Notice | OTHER | — | — | 2023 | Unaddressed |
| Revised Total Coliform Rule | REPORTING FAILURE | — | — | 2020 | Resolved |
| Total Haloacetic Acids (HAA5) | MONITORING AND REPORTING | — | 0.060 mg/L | 2020 | Resolved |
| TTHM | MONITORING AND REPORTING | — | 0.080 mg/L | 2020 | Resolved |
| E. COLI | MONITORING AND REPORTING | — | 0 | 2019 | Resolved |
| Revised Total Coliform Rule | REPORTING FAILURE | — | — | 2018 | Resolved |
| TTHM | MONITORING AND REPORTING | — | 0.080 mg/L | 2018 | Resolved |
| TTHM | MCL EXCEEDANCE | 89.6 UG/L | 0.080 mg/L | 2018 | Resolved |
| Total Haloacetic Acids (HAA5) | MONITORING AND REPORTING | — | 0.060 mg/L | 2018 | Resolved |
| Revised Total Coliform Rule | MONITORING FAILURE | — | — | 2018 | Resolved |
| TTHM | MCL EXCEEDANCE | 274 UG/L | 0.080 mg/L | 2018 | Resolved |
| Total Haloacetic Acids (HAA5) | MONITORING AND REPORTING | — | 0.060 mg/L | 2018 | Resolved |
| Total Haloacetic Acids (HAA5) | MCL EXCEEDANCE | 74.9 UG/L | 0.060 mg/L | 2018 | Resolved |
| TTHM | MONITORING AND REPORTING | — | 0.080 mg/L | 2018 | Resolved |
| E. COLI | MONITORING AND REPORTING | — | 0 | 2018 | Resolved |
| Revised Total Coliform Rule | MONITORING FAILURE | — | — | 2018 | Resolved |
| E. COLI | MONITORING AND REPORTING | — | 0 | 2018 | Resolved |
| Revised Total Coliform Rule | MONITORING FAILURE | — | — | 2018 | Resolved |
| Revised Total Coliform Rule | MONITORING FAILURE | — | — | 2018 | Resolved |
| E. COLI | MONITORING AND REPORTING | — | 0 | 2018 | Resolved |
| Total Haloacetic Acids (HAA5) | MONITORING AND REPORTING | — | 0.060 mg/L | 2018 | Resolved |
| TTHM | MCL EXCEEDANCE | 167.55 UG/L | 0.080 mg/L | 2018 | Resolved |
| TTHM | MONITORING AND REPORTING | — | 0.080 mg/L | 2018 | Resolved |
| Nitrate | MONITORING AND REPORTING | — | 10 mg/L | 2018 | Resolved |
| Lead and Copper Rule | MONITORING AND REPORTING | — | TT | 2018 | Unaddressed |
| E. COLI | MONITORING AND REPORTING | — | 0 | 2017 | Resolved |
| Revised Total Coliform Rule | MONITORING FAILURE | — | — | 2017 | Resolved |
| E. COLI | MONITORING AND REPORTING | — | 0 | 2017 | Resolved |
| TTHM | MONITORING AND REPORTING | — | 0.080 mg/L | 2017 | Resolved |
| TTHM | MCL EXCEEDANCE | 138.5333 UG/L | 0.080 mg/L | 2017 | Resolved |
| Total Haloacetic Acids (HAA5) | MONITORING AND REPORTING | — | 0.060 mg/L | 2017 | Resolved |
| E. COLI | MONITORING AND REPORTING | — | 0 | 2017 | Resolved |
| Revised Total Coliform Rule | REPORTING FAILURE | — | — | 2017 | Resolved |
| E. COLI | MONITORING AND REPORTING | — | 0 | 2017 | Resolved |
| Revised Total Coliform Rule | REPORTING FAILURE | — | — | 2017 | Resolved |
| E. COLI | MONITORING AND REPORTING | — | 0 | 2017 | Resolved |
| TTHM | MCL EXCEEDANCE | 123.325 UG/L | 0.080 mg/L | 2017 | Resolved |
| E. COLI | MONITORING AND REPORTING | — | 0 | 2016 | Resolved |
| E. COLI | MONITORING AND REPORTING | — | 0 | 2016 | Resolved |
| E. COLI | MONITORING AND REPORTING | — | 0 | 2016 | Resolved |
| E. COLI | MONITORING AND REPORTING | — | 0 | 2016 | Resolved |
| E. COLI | MONITORING AND REPORTING | — | 0 | 2016 | Resolved |
| Revised Total Coliform Rule | REPORTING FAILURE | — | — | 2016 | Resolved |
| E. COLI | MONITORING AND REPORTING | — | 0 | 2016 | Resolved |
| E. COLI | MONITORING AND REPORTING | — | 0 | 2016 | Resolved |
| E. COLI | MONITORING AND REPORTING | — | 0 | 2016 | Resolved |
| Consumer Confidence Rule | OTHER | — | — | 2016 | Resolved |
| E. COLI | MONITORING AND REPORTING | — | 0 | 2016 | Resolved |
| E. COLI | MONITORING AND REPORTING | — | 0 | 2016 | Resolved |
| E. COLI | MONITORING AND REPORTING | — | 0 | 2016 | Resolved |
| E. COLI | MONITORING AND REPORTING | — | 0 | 2016 | Addressed |
| Coliform (TCR) | MCL EXCEEDANCE | — | 5% of samples | 2016 | Archived |
| E. COLI | MONITORING AND REPORTING | — | 0 | 2016 | Resolved |
| E. COLI | MONITORING AND REPORTING | — | 0 | 2016 | Resolved |
| E. COLI | MONITORING AND REPORTING | — | 0 | 2016 | Resolved |
| Revised Total Coliform Rule | MONITORING FAILURE | — | — | 2016 | Resolved |
| E. COLI | MONITORING AND REPORTING | — | 0 | 2016 | Resolved |
| E. COLI | MONITORING AND REPORTING | — | 0 | 2016 | Resolved |
| E. COLI | MONITORING AND REPORTING | — | 0 | 2016 | Resolved |
| E. COLI | MONITORING AND REPORTING | — | 0 | 2016 | Resolved |
| Coliform (TCR) | MCL EXCEEDANCE | — | 5% of samples | 2016 | Resolved |
| E. COLI | MONITORING AND REPORTING | — | 0 | 2016 | Resolved |
| E. COLI | MONITORING AND REPORTING | — | 0 | 2016 | Resolved |
| E. COLI | MONITORING AND REPORTING | — | 0 | 2016 | Resolved |
| E. COLI | MONITORING AND REPORTING | — | 0 | 2016 | Resolved |
| Coliform (TCR) | MCL EXCEEDANCE | — | 5% of samples | 2016 | Resolved |
| E. COLI | MONITORING AND REPORTING | — | 0 | 2016 | Resolved |
| E. COLI | MONITORING AND REPORTING | — | 0 | 2016 | Resolved |
| Revised Total Coliform Rule | MONITORING FAILURE | — | — | 2016 | Resolved |
| Nitrate | MONITORING AND REPORTING | — | 10 mg/L | 2016 | Resolved |
| E. COLI | MONITORING AND REPORTING | — | 0 | 2015 | Resolved |
| Revised Total Coliform Rule | MONITORING FAILURE | — | — | 2015 | Resolved |
| E. COLI | MONITORING AND REPORTING | — | 0 | 2015 | Resolved |
| E. COLI | MONITORING AND REPORTING | — | 0 | 2015 | Resolved |
| Revised Total Coliform Rule | MONITORING FAILURE | — | — | 2015 | Resolved |
| E. COLI | MONITORING AND REPORTING | — | 0 | 2015 | Resolved |
| E. COLI | MONITORING AND REPORTING | — | 0 | 2015 | Resolved |
| E. COLI | MONITORING AND REPORTING | — | 0 | 2015 | Resolved |
| E. COLI | MONITORING AND REPORTING | — | 0 | 2015 | Resolved |
| Coliform (TCR) | MCL EXCEEDANCE | — | 5% of samples | 2015 | Resolved |
| E. COLI | MONITORING AND REPORTING | — | 0 | 2015 | Resolved |
| E. COLI | MONITORING AND REPORTING | — | 0 | 2015 | Resolved |
| E. COLI | MONITORING AND REPORTING | — | 0 | 2015 | Resolved |
| E. COLI | MONITORING AND REPORTING | — | 0 | 2015 | Resolved |
| Consumer Confidence Rule | OTHER | — | — | 2015 | Resolved |
| E. COLI | MONITORING AND REPORTING | — | 0 | 2015 | Resolved |
| E. COLI | MONITORING AND REPORTING | — | 0 | 2015 | Resolved |
| E. COLI | MONITORING AND REPORTING | — | 0 | 2015 | Resolved |
| Coliform (TCR) | MCL EXCEEDANCE | — | 5% of samples | 2015 | Resolved |
| Revised Total Coliform Rule | MONITORING FAILURE | — | — | 2015 | Resolved |
| E. COLI | MONITORING AND REPORTING | — | 0 | 2015 | Resolved |
| E. COLI | MONITORING AND REPORTING | — | 0 | 2015 | Resolved |
| E. COLI | MONITORING AND REPORTING | — | 0 | 2015 | Resolved |
| E. COLI | MONITORING AND REPORTING | — | 0 | 2015 | Resolved |
| Public Notice | OTHER | — | — | 2015 | Resolved |
| Coliform (TCR) | MCL EXCEEDANCE | — | 5% of samples | 2015 | Resolved |